Related Experiment Video
Updated: Apr 16, 2026

04:13
Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
969
Commentary on Burns et al. (2015): retention in buprenorphine treatment
1Department of Psychiatry and Behavioral Sciences, Addiction Psychiatry Residency Program, University of Washington, Center of Excellence in Substance Abuse Treatment and Education (CESATE), VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA, 98108, USA. asaxon@uw.edu.
Addiction (Abingdon, England)
|March 17, 2015
Abstract
No abstract available in PubMed .
Related Concept Videos
Drug Elimination by Renal Route: Tubular Reabsorption
5.6K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.6K
Drug Elimination by Renal Route: Tubular Secretion
3.8K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.8K
Oral Drug Delivery Systems: Continuous-Release Systems
264
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
264
Drug Elimination by Renal Route: Glomerular Filtration
7.9K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
7.9K
Drug Elimination: Non-Renal Routes
3.6K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
3.6K
Drug Elimination: The Concept of Clearance
4.5K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
4.5K

